The UK’s third-largest health insurer behind Bupa and Axa, with 1.9 million members, said it would offer discounts of up to 20% for medications such as Wegovy and Mounjaro – which are popular but pricey – to members, based on their body mass index (BMI) and weight-related health conditions.
UK health insurer Vitality to offer members discounted anti-obesity drugs Third-largest healthcare insurer will be first to give 20% off treatments such as Wegovy and Mounjaro through health cover.
Vitality has become the first health insurer in the UK to offer customers discounted weight loss treatments for up to a year through its health cover.
The use of anti-obesity drugs aims to build on Vitality’s existing weight loss programme, which uses reward-based incentives to encourage customers to adopt a healthier lifestyle through better diet and more exercise, with nearly half (48%) of enrolled members reaching their targets of about 5% weight loss.
Dr Katie Tryon, chief commercial director at Vitality, which is part of the South African insurance group Discovery Limited, said: “While some risk factors are reducing in the workplace, like smoking and alcohol … the ones that are coming out as ever increasing are the number of people living with obesity as well as mental health and MSK [musculoskeletal] issues.”.
